Clinical Trials Investigating Potential Treatments for PSP

Clinical Trials Investigating Potential Treatments for PSP

Progressive supranuclear palsy (PSP) is a rare and progressive neurodegenerative disorder for which there is currently no cure. However, there are ongoing clinical trials investigating potential treatments for PSP. These trials aim to evaluate the safety and effectiveness of various drugs and therapies in reducing the symptoms of PSP and slowing its progression.

Some of the drugs that are being studied in clinical trials for PSP include:

  1. Tau protein inhibitors: PSP is characterized by the accumulation of abnormal tau protein in the brain. Tau protein inhibitors are drugs that target the tau protein and aim to reduce its accumulation. Some examples of tau protein inhibitors being studied in PSP trials include LMTX, TPI-287, and RO7105705.

  2. Anti-inflammatory drugs: Inflammation in the brain may contribute to the progression of PSP. Anti-inflammatory drugs, such as pioglitazone and dextromethorphan, are being investigated in clinical trials to see if they can reduce inflammation and slow down the progression of PSP.

  3. Glutamate modulators: Glutamate is a neurotransmitter that is involved in many brain functions, including learning and memory. However, excessive glutamate release can be toxic to brain cells, and may contribute to neurodegeneration in PSP. Glutamate modulators, such as riluzole and memantine, are being studied to see if they can reduce glutamate toxicity and improve symptoms in PSP patients.

  4. Stem cell therapy: Stem cells have the ability to differentiate into various types of cells, and may be able to repair damaged brain tissue in PSP. Clinical trials are underway to investigate the safety and effectiveness of stem cell therapy in treating PSP.

It is important to note that clinical trials for PSP are still in the early stages, and more research is needed to determine the safety and effectiveness of these treatments. If you or a loved one is interested in participating in a clinical trial for PSP, you should talk to your doctor and research clinical trials in your area.

Back to blog

1 comment

Interested in participating in these clinical trials.

Valerie Thomas

Leave a public comment:

Please note, comments need to be approved before they are published.

  • Introducing the CCF Awareness Shop for Atypical Parkinsonism: Wear It, Share It, Support It

    Introducing the CCF Awareness Shop for Atypical...

    We’re excited to unveil the CCF Coleen Cunningham Foundation Awareness Shop—a new way to raise awareness for atypical parkinsonism and support our mission at the same time! At CCF, we’re...

    Introducing the CCF Awareness Shop for Atypical...

    We’re excited to unveil the CCF Coleen Cunningham Foundation Awareness Shop—a new way to raise awareness for atypical parkinsonism and support our mission at the same time! At CCF, we’re...

  • The Ustep Walker: A Game-Changer for Atypical Parkinsonism

    The Ustep Walker: A Game-Changer for Atypical P...

      The Ustep walker is a specialized mobility aid designed to support individuals with neurological conditions, including atypical Parkinsonism. Unlike standard walkers, the Ustep is engineered with features that address...

    The Ustep Walker: A Game-Changer for Atypical P...

      The Ustep walker is a specialized mobility aid designed to support individuals with neurological conditions, including atypical Parkinsonism. Unlike standard walkers, the Ustep is engineered with features that address...

  • Understanding Atypical Parkinsonism: A Brain Awareness Week Spotlight

    Understanding Atypical Parkinsonism: A Brain Aw...

    As we celebrate Brain Awareness Week this March 2025, it’s the perfect time to shine a light on the incredible complexity of the human brain—and the challenges it faces when...

    Understanding Atypical Parkinsonism: A Brain Aw...

    As we celebrate Brain Awareness Week this March 2025, it’s the perfect time to shine a light on the incredible complexity of the human brain—and the challenges it faces when...

  • Celebrating Brain Awareness Week 2025 with CCF: Shining a Light on Brain Health

    Celebrating Brain Awareness Week 2025 with CCF:...

    At the Coleen Cunningham Foundation (CCF), we’re excited to join the global community in recognizing Brain Awareness Week, running from March 10-16, 2025. This annual campaign, led by the Dana...

    Celebrating Brain Awareness Week 2025 with CCF:...

    At the Coleen Cunningham Foundation (CCF), we’re excited to join the global community in recognizing Brain Awareness Week, running from March 10-16, 2025. This annual campaign, led by the Dana...

1 of 4